ductal carcinoma

Summary

Summary: Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND.

Top Publications

  1. Sakr R, Bezu C, Raoust I, Antoine M, Ettore F, Darcourt J, et al. The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes. Int J Clin Pract. 2008;62:1730-5 pubmed publisher
    Occult invasive disease could be found at definitive histology in patients initially diagnosed with large ductal carcinoma in situ (DCIS)...
  2. Prat A, Parera M, Reyes V, Peralta S, Cedres S, Andreu J, et al. Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy. Head Neck. 2008;30:680-3 pubmed
    Salivary ductal carcinoma (SDC) is an uncommon malignant tumor of the salivary glands...
  3. Mendrinos S, Nolen J, Styblo T, Carlson G, Pohl J, Lewis M, et al. Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry. Cancer. 2005;105:178-83 pubmed
  4. Polom K, Murawa D, Wasiewicz J, Nowakowski W, Murawa P. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2009;35:43-7 pubmed publisher
    ..alternative to lymphadenectomy in the case of invasive breast carcinoma, although the sentinel node's role in ductal carcinoma in situ (DCIS) diagnosed on core needle biopsy has not been well defined nevertheless guidelines recommend ..
  5. Raza S, Vallejo M, Chikarmane S, Birdwell R. Pure ductal carcinoma in situ: a range of MRI features. AJR Am J Roentgenol. 2008;191:689-99 pubmed publisher
    ..and illustrate the variety of common morphologic features, enhancement patterns, and kinetics of pure ductal carcinoma in situ (DCIS) on dynamic contrast-enhanced MRI of the breast, using the American College of Radiology BI-..
  6. Behbod F, Kittrell F, LaMarca H, Edwards D, Kerbawy S, Heestand J, et al. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 2009;11:R66 pubmed publisher
    ..b>Ductal carcinoma in situ (DCIS) is the most common type (80%) of noninvasive breast lesions...
  7. Vazmitel M, Spagnolo D, Nemcova J, Michal M, Kazakov D. Hidradenoma papilliferum with a ductal carcinoma in situ component: case report and review of the literature. Am J Dermatopathol. 2008;30:392-4 pubmed publisher
    ..Malignant change in HP is extremely rare. Only a single case of ductal carcinoma in situ arising in HP has been previously reported...
  8. Mariano M, van den Bosch M, Daniel B, Nowels K, Birdwell R, Fong K, et al. Contrast-enhanced MRI of ductal carcinoma in situ: characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings. J Magn Reson Imaging. 2005;22:520-6 pubmed
    To identify morphologic and dynamic enhancement magnetic resonance imaging (MRI) features of pure ductal carcinoma in situ (DCIS) by using a new intensity-modulated parametric mapping technique, and to correlate the MRI features with ..
  9. Diaz R, Babu S. Ductal carcinoma arising from syringocystadenoma papilliferum in the external auditory canal. Otol Neurotol. 2007;28:873-4 pubmed

More Information

Publications80

  1. Zavagno G, Carcoforo P, Marconato R, Franchini Z, Scalco G, Burelli P, et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer. 2005;5:28 pubmed
    ..This procedure has been recently proposed as part of the treatment for patients with ductal carcinoma in situ (DCIS), because cases of undetected invasive foci and nodal metastases occasionally occur...
  2. Vizoso F, Gonzalez L, Corte M, Rodriguez J, Vazquez J, Lamelas M, et al. Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer. 2007;96:903-11 pubmed
  3. Wen Y, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O. Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep. 2007;18:1387-93 pubmed
    ..We observed primarily nuclear localization of PDCD4 in ductal carcinoma in situ compared to normal breast tissues where the PDCD4 expression was predominantly cytoplasmic...
  4. Frech M, Halama E, Tilli M, Singh B, Gunther E, Chodosh L, et al. Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res. 2005;65:681-5 pubmed
    ..alpha expression in mammary epithelial cells developed ductal hyperplasia (DH), lobular hyperplasia, and ductal carcinoma in situ (DCIS) by 4 months of age...
  5. Albores Saavedra J, Simpson K, Dancer Y, Hruban R. Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas. Ann Diagn Pathol. 2007;11:3-9 pubmed
    ..Six patients died as a direct result of the carcinomas, and 1 was lost to follow-up. More studies are needed to determine the biologic behavior of this distinctive histologic variant of ductal adenocarcinoma of the pancreas...
  6. Park S, Koo J, Kim J, Yang W, Park B, Lee K. Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified. J Korean Med Sci. 2010;25:361-8 pubmed publisher
    ..characteristics and prognostic factors of mucinous carcinoma (MC) were compared with invasive ductal carcinoma-not otherwise specified (IDC-NOS)...
  7. Mitsunaga S, Hasebe T, Iwasaki M, Kinoshita T, Ochiai A, Shimizu N. Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci. 2005;96:858-65 pubmed
    For clinicians, the orthodox histological investigation of patients with invasive ductal carcinoma (IDC) remains important for predicting prognoses...
  8. Lui E, Loo W, Zhu L, Cheung M, Chow L. DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma. Biomed Pharmacother. 2005;59 Suppl 2:S363-5 pubmed
    ..This study focused on the hypermethylation status of the TIMP3 gene with clinical parameters in invasive breast ductal carcinoma (IDC) samples.
  9. Leong P, Mohammad R, Ibrahim N, Ithnin H, Abdullah M, Davis W, et al. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Immunol Lett. 2006;102:229-36 pubmed
    ..lymphocytes (TILs) from 47 enzymatically dissociated tumour specimens from patients with infiltrating ductal carcinoma (IDC) of the breast...
  10. Chen Y, Devries S, Anderson J, Lessing J, Swain R, Chin K, et al. Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ. BMC Cancer. 2009;9:285 pubmed publisher
    Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma in situ (DCIS)...
  11. Miki Y, Suzuki T, Sasano H. Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast. J Steroid Biochem Mol Biol. 2009;114:68-71 pubmed
    ..through intratumoral production in an intracrine manner, play important roles in the development of invasive ductal carcinoma (IDC) of human breast, but biological and/or clinical significance of intratumoral production and metabolism ..
  12. Pervatikar S, Rao R, Dinesh U, Parameswaraiah S. Large mammary hamartoma with focal invasive ductal carcinoma. Indian J Pathol Microbiol. 2009;52:249-51 pubmed
    ..Fine needle aspiration cytology showed features of invasive ductal carcinoma along with normal benign glands that were mistaken for normal breast tissue...
  13. Korourian S, Siegel E, Kieber Emmons T, Monzavi Karbassi B. Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry. BMC Cancer. 2008;8:136 pubmed publisher
    The number of breast cancer patients diagnosed with ductal carcinoma in situ (DCIS) continues to grow. Laboratory and clinical data indicate that DCIS can progress to invasive disease...
  14. Hu M, Peluffo G, Chen H, Gelman R, Schnitt S, Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci U S A. 2009;106:3372-7 pubmed publisher
    ..previously described that fibroblasts promote, whereas normal myoepithelial cells inhibit, the progression of ductal carcinoma in situ (DCIS) to invasive breast carcinomas by using a xenograft model of human DCIS...
  15. Gotohda N, Nakagohri T, Saito N, Ono M, Sugito M, Ito M, et al. A case of anaplastic ductal carcinoma of the pancreas with production of granulocyte-colony stimulating factor. Hepatogastroenterology. 2006;53:957-9 pubmed
    We report a case of anaplastic ductal carcinoma of the pancreas with production of granulocytecolony stimulating factor in a 46-year-old man...
  16. Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N. Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma. Pancreas. 2006;33:233-9 pubmed
    Recent advances in diagnostic modalities have made it possible to detect small pancreatic ductal carcinoma and to increase the number of resected cases. However, the postoperative prognosis remains dismal.
  17. Desmetz C, Bibeau F, Boissiere F, Bellet V, Rouanet P, Maudelonde T, et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J Proteome Res. 2008;7:3830-7 pubmed publisher
    ..autoantibodies directed against this protein in the sera of 240 individuals, comprising patients with either ductal carcinoma in situ (DCIS) ( n = 49) or early stage breast cancer ( n = 58), other cancers ( n = 20), autoimmune disease (..
  18. Vag T, Baltzer P, Renz D, Pfleiderer S, Gajda M, Camara O, et al. Diagnosis of ductal carcinoma in situ using contrast-enhanced magnetic resonance mammography compared with conventional mammography. Clin Imaging. 2008;32:438-42 pubmed publisher
    The objective of this study is to compare mammography with magnetic resonance mammography (MRM) in the diagnosis of histopathologically verified subtypes of ductal carcinoma in situ (DCIS).
  19. Wagoner M, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009;131:112-21 pubmed publisher
    ..We found that ADH present in more than 2 foci in CNB specimens was a strong predictor of ductal carcinoma in situ (DCIS) on excision (>2 foci, 16/41 vs 6/82 for 1 or 2 foci; P < .0001)...
  20. Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Anticancer Res. 2005;25:1719-23 pubmed
  21. Chahed K, Kabbage M, Ehret Sabatier L, Lemaitre Guillier C, Remadi S, Hoebeke J, et al. Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses. Int J Oncol. 2005;27:1425-31 pubmed
    In the present study, total proteins from a tissue of an infiltrating ductal carcinoma of the breast (IDCA) were compared by the two-dimensional electrophoresis (2D-PAGE) to proteins from an adjacent non-neoplastic breast tissue...
  22. Gao R, Bao H, Yang Q, Cong Q, Song J, Wang L. The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters. Breast Cancer Res Treat. 2005;93:111-5 pubmed
    ..One hundred and forty-four patients with invasive ductal carcinoma of breast were involved in this study...
  23. Gonzalez Angulo A, Sahin A, Krishnamurthy S, Yang Y, Kau S, Hortobagyi G, et al. Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin Breast Cancer. 2006;7:396-400 pubmed
    ..expression of established histopathologic and biologic markers of proliferation, apoptosis, and angiogenesis in invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) in a group of axillary node-negative breast cancers.
  24. Hugel H, Requena L. Ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn. Am J Dermatopathol. 2003;25:490-3 pubmed
    We present an example of ductal carcinoma connected to a syringocystadenoma papilliferum situated in a nevus sebaceus of Jadassohn on the scalp of a 22-year-old woman...
  25. Zhao Y, Xiao A, Park H, Newcomer R, Yan M, Man Y, et al. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res. 2004;64:590-8 pubmed
    ..membrane is an indispensable prerequisite for the initiation of invasion and the conversion of human breast ductal carcinoma in situ (DCIS) to infiltrating ductal carcinoma (IDC)...
  26. North W, Wells W, Fay M, Mathew R, Donnelly E, Memoli V. Immunohistochemical evaluation of vasopressin expression in breast fibrocystic disease and ductal carcinoma in situ (DCIS). Endocr Pathol. 2003;14:257-62 pubmed
    ..Alternatively, we examined 16 cases of breast ductal carcinoma in situ (DCIS) using the second of these antibodies (anti-VAG), and all of these cases were positive for ..
  27. Law W, Chu K. Scirrhous colonic metastasis from ductal carcinoma of the breast: report of a case. Dis Colon Rectum. 2003;46:1424-7 pubmed
    ..The histologic diagnosis is consistent with colonic metastasis from ductal carcinoma of breast origin...
  28. Tsutsui S, Kume M, Era S. Prognostic value of microvessel density in invasive ductal carcinoma of the breast. Breast Cancer. 2003;10:312-9 pubmed
    ..Although the prognostic value of microvessel density (MVD) has been studied in breast cancer, the results still remain controversial...
  29. Diallo R, Schaefer K, Bankfalvi A, Decker T, Ruhnke M, Wülfing P, et al. Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry. Hum Pathol. 2003;34:1299-305 pubmed
    ..These results support the hypothesis that SCAs have immunohistochemical and genetic features that distinguish them from IDCs of the usual type...
  30. Yoshida K, Ueno S, Iwao T, Yamasaki S, Tsuchida A, Ohmine K, et al. Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma. Cancer Sci. 2003;94:263-70 pubmed
    Pancreatic ductal carcinoma (PDC) is one of the most intractable human malignancies. Surgical resection of PDC at curable stages is hampered by a lack of sensitive and reliable detection methods...
  31. McCann J, Treasure P, Duffy S. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme. J Med Screen. 2004;11:117-25 pubmed
  32. Namba R, Maglione J, Young L, Borowsky A, Cardiff R, MacLeod C, et al. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. Mol Cancer Res. 2004;2:453-63 pubmed
    A transplantable model of human ductal carcinoma in situ that progresses to invasive carcinoma was developed from a genetically engineered mouse (GEM)...
  33. Kricker A, Goumas C, Armstrong B. Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology. Br J Cancer. 2004;90:1382-5 pubmed
    In a population-based series of 2109 women with ductal carcinoma in situ (DCIS) diagnosed in 1995-2000 in New South Wales, Australia, incidence increased by an average of 5...
  34. Tagawa Y, Yasutake T, Ikuta Y, Oka T, Terada R. Chromosome 8 numerical aberrations in stage II invasive ductal carcinoma: correlation with patient outcome and poor prognosis. Med Oncol. 2003;20:127-36 pubmed
    ..Our results suggest that the frequencies of chromosome 8 gain and disomy is a potentially useful parameter for predicting prognosis of stage II IDCs...
  35. Himmelfarb M, Klopocki E, Grube S, Staub E, Klaman I, Hinzmann B, et al. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer. Cancer Lett. 2004;204:69-77 pubmed
    ..epithelial cells clearly express ITIH5, expression is consistantly lost or strongly downregulated in invasive ductal carcinoma. ITIH5 mRNA was neither detectable in cancerous nor benign breast cell lines...
  36. Manders J, Kuerer H, Smith B, McCluskey C, Farrar W, Frazier T, et al. Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ. Ann Surg Oncol. 2017;24:660-668 pubmed publisher
    ..of the results of the 12-gene DCIS Score assay on (i) radiotherapy recommendations for patients with pure ductal carcinoma in situ (DCIS) following breast-conserving surgery (BCS), and (ii) patient decisional conflict and state ..
  37. Sun X, Liu J, Wang Y, Wang L, Yang G, Zhou Z, et al. Roles of preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer patients. Jpn J Clin Oncol. 2010;40:722-5 pubmed publisher
  38. Paryan M, Tavakoli R, Rad S, Feizi N, Kamani F, Mostafavi E, et al. Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma. 3 Biotech. 2016;6:58 pubmed publisher
    Breast cancer is the leading cause of cancer-related death in women worldwide. Invasive ductal carcinoma (IDC) is the most frequent invasive form of breast cancer followed by metastasis...
  39. Accurso A, Ciancia G, Della Corte G, Reale P, Accardo G, Salerno C, et al. A rare case of true carcinosarcoma of the breast. Int J Surg Case Rep. 2016;21:125-8 pubmed publisher
    ..are still unclear because of the rarity of this condition, but Breast Conserving Treatment (BCT) followed by adjuvant chemotherapy seems to provide a prognosis equalling that of usual Invasive Ductal Carcinoma of the breast.
  40. Guraya S, Khairy G. Bilateral synchronous breast cancer. A clinical dilemma. Saudi Med J. 2004;25:2024-5 pubmed
  41. Cho S. APC downregulated 1 inhibits breast cancer cell invasion by inhibiting the canonical WNT signaling pathway. Oncol Lett. 2017;14:4845-4852 pubmed publisher
    ..which was consistent with previous studies that indicated that APCDD1 expression was decreased in invasive ductal carcinoma compared with that in ductal carcinoma in situ...
  42. Dabbs D, Chivukula M, Carter G, Bhargava R. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile. Mod Pathol. 2006;19:1506-11 pubmed
    ..All 16 cases had a high-grade invasive ductal carcinoma, Nottingham score 9/9, with geographic necrosis, good circumscription and lymphoid infiltrates...
  43. Swain S, Nunes R, Yoshizawa C, Rothney M, Sing A. Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age. Adv Ther. 2015;32:1222-36 pubmed publisher
    ..6% (n = 61,643) aged ≥70 years] were included; 81.6% of patients had invasive ductal carcinoma. Nodal status was specified for 362,001 patients (87.0% negative)...
  44. Katsumori T, Hamaguchi H, Yamamoto S, Tsukamoto Y, Ohshima H, Ohkawara S, et al. [A Case of Recurrent Inflammatory Breast Cancer Treated Using Multidisciplinary Therapy]. Gan To Kagaku Ryoho. 2016;43:2054-2055 pubmed
    ..The pathological diagnosis ofthe tumor was noninvasive ductal carcinoma, TisN0M0 and Stage 0...
  45. Shan N, Wahler J, Lee H, Bak M, Gupta S, Maehr H, et al. Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer. J Steroid Biochem Mol Biol. 2017;173:122-129 pubmed publisher
    ..shown that vitamin D compounds, including a Gemini vitamin D analog BXL0124, suppress progression of ductal carcinoma in situ in vivo and inhibit cancer stem-like cells in MCF10DCIS mammosphere cultures...
  46. Carrascal M, Silva M, Ramalho J, Pen C, Martins M, Pascoal C, et al. Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation and ERK1/2 and p38 MAPK activation. Mol Oncol. 2017;: pubmed publisher
    ..These data indicate that fucosylation licenses several malignant features of IDC, such as cell adhesion, migration, proliferation and growth factor expression, contributing to tumor progression...
  47. Bremm A, Walch A, Fuchs M, Mages J, Duyster J, Keller G, et al. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. Cancer Res. 2008;68:707-14 pubmed publisher
    ..In summary, we describe activation of EGFR by mutant E-cadherin as a novel mechanism in tumor cells that explains the enhanced motility of tumor cells in the presence of an extracellular mutation of E-cadherin. ..
  48. Orihuela E, Green J. Ductal prostate cancer: contemporary management and outcomes. Urol Oncol. 2008;26:368-71 pubmed publisher
    ..Metastatic sites include brain, lung, peritoneum, and anterior urethra, and most patients respond well to endocrine treatment. ..
  49. Döppler H, Bastea L, Borges S, Geiger X, Storz P. The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma. Oncotarget. 2015;6:29740-52 pubmed publisher
    ..the expression levels of PKD2, the kinase that phosphorylates VASP at this site, are decreased in invasive ductal carcinoma samples of all three groups...
  50. King T, Pilewskie M, Muhsen S, Patil S, Mautner S, Park A, et al. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. J Clin Oncol. 2015;33:3945-52 pubmed publisher
    ..developed 168 breast cancers (63% ipsilateral, 25% contralateral, 12% bilateral), with no dominant histology (ductal carcinoma in situ, 35%; infiltrating ductal carcinoma, 29%; infiltrating lobular carcinoma, 27%; other, 9%)...
  51. Heymans C, van Bastelaar J, Visschers R, Vissers Y. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ. Clin Breast Cancer. 2017;17:e87-e93 pubmed publisher
    Patients with a preoperative needle-biopsy diagnosis of ductal carcinoma in situ (DCIS) may have an indication for a sentinel lymph node biopsy if invasive carcinoma is found...
  52. Lehman C, Deperi E, Peacock S, McDonough M, Demartini W, Shook J. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2005;184:1782-7 pubmed
    ..One of two lesions with atypical ductal hyperplasia was upgraded to ductal carcinoma in situ after surgery, for an overall cancer yield of 40% (15/38)...
  53. Hou Y, Chaudhary S, Gao F, Li Z. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy. Ann Diagn Pathol. 2016;24:4-6 pubmed publisher
    ..or carcinoma in core biopsy, none of the follow-up excision specimens after a diagnosis of AA or AAA showed ductal carcinoma in situ or invasive carcinoma...
  54. Piot Ziegler C, Sassi M, Raffoul W, Delaloye J. Mastectomy, body deconstruction, and impact on identity: a qualitative study. Br J Health Psychol. 2010;15:479-510 pubmed publisher
    ..This qualitative study aims at understanding the consequences of body deconstruction through mastectomy on corporality and identity in women with breast cancer...
  55. Hungermann D, Decker T, Burger H, Kersting C, Bocker W. [Papillary tumors of the breast]. Pathologe. 2006;27:350-7 pubmed
    ..These lesions must be distinguished from the papillary type of ductal carcinoma in situ...
  56. Lutz M, Pourebrahim S. [Pancreatic carcinoma]. Internist (Berl). 2008;49:1079-86; quiz 1087 pubmed publisher
    ..Locally advanced or metastatic tumors are treated symptomatically including pain medication and biliary drainage in the case of jaundice. There is a benefit from systemic chemotherapy mainly in patients with good performance status...
  57. Padberg B, Sasse B, Huber A, Pfaltz M. Sarcomatoid salivary duct carcinoma. Ann Diagn Pathol. 2005;9:86-92 pubmed
    ..The use of the term SSDC seems more appropriate than the term carcinosarcoma , as the immunohistochemical, electron microscopic, and recent molecular findings in this and other biphasic neoplasms imply a monoclonal origin...
  58. Cao W, Wang X, Frappart L, Rigal D, Wang Z, Shen Y, et al. Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients. Mutat Res. 2007;632:20-8 pubmed
    ..The present study implies that genetic variants of PARP-1 may contribute to breast cancerogenesis and that PARP-1 htSNP c.852T>C (Ala284Ala) may influence hormonal therapy of breast cancer...
  59. Lee S, Ross R, Pike M. An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer. 2005;92:2049-58 pubmed
    ..We observed no overall difference in risk for lobular vs ductal carcinoma but did observe a slightly higher risk for current vs past EPT use.
  60. Hershkovitz O, Jivov S, Bloushtain N, Zilka A, Landau G, Bar Ilan A, et al. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry. 2007;46:7426-36 pubmed
    ..Thus, we suggest that heparan sulfate epitope(s) are ligands/co-ligands of NKp44 and are involved in its tumor recognition ability...
  61. Baratelli G, Ciccaglioni B, Dainese E, Arnaboldi L. Metastasis of breast carcinoma to intracranial meningioma. J Neurosurg Sci. 2004;48:71-3 pubmed
    ..The lesion may be a primary cerebral malignancy, a metastatic lesion, or a meningioma with or without a metastatic lesion...
  62. Swiatoniowski G, Matkowski R, Suder E, Bruzewicz S, Setta M, Kornafel J, et al. E-cadherin and fibronectin expressions have no prognostic role in stage II ductal breast cancer. Anticancer Res. 2005;25:2879-83 pubmed
    ..The aim of the study was to describe the expressions of E-cadherin (EC) and fibronectin (FN) and their prognostic value in radically-treated ductal breast cancer...
  63. Sohn D, Kim S, Baek M, Lim C, Lee M, Cho M, et al. Expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacother. 2006;60:289-92 pubmed
    ..168), although the decrease in the survival rate of survivin-positive patients did reach statistical significance (P=0.048)...
  64. Dura E, Andreu Y, Galdón M, Ibáñez E, Perez S, Ferrando M, et al. Emotional suppression and breast cancer: validation research on the Spanish Adaptation of the Courtauld Emotional Control Scale (CECS). Span J Psychol. 2010;13:406-17 pubmed
    ..In short, our results support the reliability, validity and utility of this Spanish adaptation of the CECS in clinical and research settings...
  65. Goldschmidt B, Marchevsky R, Andrade M, Lopes C, Gonçalves M, Marinho A, et al. Studies on argyrophilic nucleolar organizer regions (AgNORs) in a spontaneous mammary gland ductal carcinoma of a captive rhesus monkey. Exp Toxicol Pathol. 2007;58:361-5 pubmed
    A spontaneous mammary gland ductal carcinoma was diagnosed in a 13-year-old female captive rhesus monkey (Macaca mulatta)...
  66. Sweeney C, Baumgartner K, Byers T, Giuliano A, Herrick J, Murtaugh M, et al. Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control. 2008;19:391-401 pubmed
    ..To evaluate reproductive history risk factors in breast cancer among Hispanic (HISP) women in the U.S. southwest, a population with approximately 33% lower breast cancer incidence than non-Hispanic whites (NHW)...
  67. Nashed M, Casasola R. Biological therapy of salivary duct carcinoma. J Laryngol Otol. 2009;123:250-2 pubmed publisher
    ..Salivary duct carcinoma has significant pathological similarities to ductal carcinoma of the breast.
  68. Jung E, Jungius K, Rupp N, Gallegos M, Ritter G, Lenhart M, et al. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results. Clin Hemorheol Microcirc. 2005;33:109-20 pubmed
    ..To investigate the extent to which indeterminate lesions of the breast can be differentiated in the early and late phase after bolus injection of the ultrasound contrast medium Optison...
  69. Chen J, Gomes A, Monteiro L, Wong S, Wu L, Ng T, et al. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer. PLoS ONE. 2010;5:e12293 pubmed publisher
    ..The PI3K-Akt signal pathway plays a key role in tumorigenesis and the development of drug-resistance. Cytotoxic chemotherapy resistance is linked to limited therapeutic options and poor prognosis...
  70. Atik E, Akansu B, Bakaris S, Aban N. Expression of cyclooxygenase-2 and its relation to histological grade, inducible nitric oxide synthase, matrix metalloproteinase-2, CD-34, Caspase-3, and CD8 in invasive ductal carcinoma of the breast. Saudi Med J. 2010;31:130-4 pubmed
    To assess by immunohistochemistry the cyclooxygenase-2 (COX-2) expression in invasive ductal carcinoma and its possible correlation with the histological grade, inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP2), ..
  71. Takano A, Hirotsu Y, Amemiya K, Nakagomi H, Oishi N, Oyama T, et al. Genetic basis of a common tumor origin in the development of pancreatic mixed acinar-neuroendocrine-ductal carcinoma: A case report. Oncol Lett. 2017;14:4428-4432 pubmed publisher
    ..from exocrine glands and neuroendocrine cells from endocrine glands; however, mixed acinar-neuroendocrine-ductal carcinoma has different histological carcinomas coexisting within a nodule...